fda removes semaglutide shortage list 2025 GLP-1 No Longer on FDA's Drug US FDA proposes curbs on

Appetite and weight changes drive many lab moves, with 75% of patients reporting decreased appetite and clinical trials showing an average 10% body weight reduction over 68 weeks, which explains the typical improvements in glucose and lipid levels

Compounded medications are usually not eligible for insurance because they are not FDA approved

If you suspect an allergic reaction, call 911 immediately

So, health reasons were my number one priority for using semaglutide for weight loss, but of course as a woman dealing with body image issues, I was interested to see if I could also get back into some of my old clothes and get back to feeling like ME